Rubric Capital Management LP Ocular Therapeutix, Inc Transaction History

Rubric Capital Management LP

  • $3.59 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$6.16 - $12.07 $2.19 Million - $4.28 Million
-354,728 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$9.7 - $14.34 $17.5 Million - $25.8 Million
-1,801,814 Reduced 83.55%
354,728 $3.55 Million
Q2 2021

Aug 13, 2021
BUY
$13.43 - $19.16 $23.8 Million - $34 Million
1,774,156 Added 463.97%
2,156,542 $30.6 Million
Q1 2021

May 14, 2021
BUY
$15.82 - $22.11 $6.05 Million - $8.45 Million
382,386 New
382,386 $6.28 Million

Others Institutions Holding OCUL

# of Institutions
171
Shares Held
138M
Call Options Held
150K
Put Options Held
225K
View Full List

About OCULAR THERAPEUTIX, INC

OCUL Quotes by TradingView
  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $654M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Rubric Capital Management LP Portfolio

Follow Rubric Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rubric Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rubric Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email